Table 2.
Adverse cardiovascular outcomes by quartile of LVPMR
| LVPMR quartiles, W/kg |
HR1, 95% CI | P | ||||
|---|---|---|---|---|---|---|
| quartile 1 (0.95–6.68) | quartile 2 (6.69–9.20) | quartile 3 (9.22–12.12) | quartile 4 (12.15–38.03) | value | ||
| All-cause mortality | 62 (27%) | 36 (16%) | 37 (16%) | 25 (11%) | 3.0, 1.9–4.8 | <0.001 |
| Cardiovascular death | 23 (10%) | 7 (3%) | 8 (4%) | 7 (3%) | 3.8, 1.6–8.8 | 0.002 |
| Heart failure hospitalization | 47 (21%) | 17 (7%) | 23 (10%) | 9 (4%) | 6.2,3.0–12.6 | <0.001 |
| Nonfatal myocardial infarction | 28 (12%) | 21 (9%) | 15 (7%) | 15 (7%) | 2.2, 1.2–4.0 | 0.02 |
| Cardiovascular events | 67 (29%) | 35 (15%) | 39 (17%) | 23 (10%) | 3.5,2.2–5.6 | <0.001 |
1
Quartile 1 versus quartile 4.